首页 | 本学科首页   官方微博 | 高级检索  
     


The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Authors:Thomas Spangenberg  Jeremy N. Burrows  Paul Kowalczyk  Simon McDonald  Timothy N. C. Wells  Paul Willis
Affiliation:1. Medicines for Malaria Venture (MMV), Geneva, Switzerland.; 2. SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America.; National University of Singapore, Singapore,
Abstract:Historically, one of the key problems in neglected disease drug discovery has been identifying new and interesting chemotypes. Phenotypic screening of the malaria parasite, Plasmodium falciparum has yielded almost 30,000 submicromolar hits in recent years. To make this collection more accessible, a collection of 400 chemotypes has been assembled, termed the Malaria Box. Half of these compounds were selected based on their drug-like properties and the others as molecular probes. These can now be requested as a pharmacological test set by malaria biologists, but importantly by groups working on related parasites, as part of a program to make both data and compounds readily available. In this paper, the analysis and selection methodology and characteristics of the compounds are described.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号